Cyclic RGD Motif Enhances Integrin Selectivity in Cell Scaffolds

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cell culture methods struggle to maintain the original phenotype of cells in vitro, particularly in terms of integrin binding, which is crucial for processes like differentiation and proliferation, and often rely on animal-derived substrates, limiting the availability of efficient and selective cell scaffolds for wound healing and tissue engineering.

Innovation Solution

Development of a cyclic RGD cell-binding motif comprising the amino acid sequence C1-X1-X2-RGDX3-X4-X5-C2, where X1, X2, X3, X4, and X5 are natural amino acids other than cysteine, and C1 and C2 are connected via a disulphide bond, which is incorporated into recombinant proteins and fusion proteins to enhance cell adhesion and selectivity for integrins like α5β1.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If animal-derived ECM substrates are used for cell culture, then cell adhesion and phenotype maintenance are improved, but the availability and selectivity for specific integrins are limited

Engineering Contradiction:
Improvecell adhesionVSAvoidintegrin selectivity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention segments the complex animal-derived ECM into specific functional motifs (RGD sequences) that can be independently selected and optimized for different integrin types, allowing tailored cell scaffold compositions for specific cellular responses

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention creates composite cell scaffold materials by combining purified protein matrices with specifically selected RGD-containing peptides or protein fragments, achieving both reliable cell adhesion and integrin-specific signaling capabilities

Inventive Principle:
Principle #40Composite materials

2Reliability

If short RGD peptides are used to enhance integrin binding, then cell adhesion efficacy is improved, but the affinity and selectivity for specific integrins are reduced

Engineering Contradiction:
Improvecell adhesion efficacyVSAvoidintegrin binding affinity
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The invention optimizes parameters including RGD peptide sequence variations, flanking amino acid compositions, peptide-to-matrix ratio, and crosslinking conditions to achieve both high cell adhesion efficacy and specific integrin affinity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention combines short RGD peptides with larger protein structures or uses RGD-containing protein fragments that provide both the adhesive functionality and the structural context needed for high-affinity, selective integrin binding

Inventive Principle:
Principle #40Composite materials

3Reliability

If ECM proteins are used to coat cell culture surfaces, then integrin binding is provided, but the use of animal-derived substrates is required

Engineering Contradiction:
Improveintegrin bindingVSAvoidsubstrate availability
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The invention extracts and isolates the essential functional element (RGD sequences) from complex animal-derived ECM proteins, enabling the production of defined, synthetic, or recombinant cell scaffold materials that maintain integrin binding capability without requiring animal substrates

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention creates simplified copies or mimics of the essential adhesive functions of ECM proteins using synthetic peptides or recombinant protein domains containing RGD motifs, which can be produced through defined manufacturing processes

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The cyclic RGD motif significantly increases cell adhesion efficacy and promotes proliferation and migration of primary cells, supporting efficient cell expansion and wound healing by providing a selective and potent integrin-binding surface without the need for animal-derived materials.

Implementation Method 1

C1 and C2 are connected via a disulphide bond

Methodology Applied
Scientific EffectDisulphide bond: Chemical Bonding

Data Source

PatentEP3313869B1Cyclic RGD cell-binding motif and uses thereof
Publication Date: 2021.02.17 SPIBER TECHNOLOGIES AB
  • EP3313869B1 patent drawingFigure 1a~1c
  • EP3313869B1 patent drawingFigure 2a~2b
  • EP3313869B1 patent drawingFigure 3a

AI summary

A recombinant fusion protein is comprising a spider silk fragment and a cyclic RGD cell-binding motif with selectivity for integrins, such as for α5β1 integrins. The fusion protein is useful as a cell scaffold material and for the cultivation of cells displaying integrins on their cell surface.